LivaNova (NSDQ:LIVN) said last week that it picked up former Johnson & Johnson medical device group chief financial officer Thad Huston as its new CFO, effective May 20.
Huston will replace former CFO Vivid Sehgal, who coordinated with Huston during the transition. Huston spent more than 25 years with Johnson & Johnson, and held various positions, including prez of its Xian-Janssen Pharmaceuticals division in China, finance VP and CFO & COO for its pharmaceutical R&D and finance VP and CFO for its Ortho-McNeil Pharma division.
“I am eager to join the exceptional team at LivaNova. We share a passion for making a difference in patients’ lives, while focusing on growth that will lead us to even greater success as a company,” Huston said in a prepared statement.
“I am pleased to welcome Thad Huston to LivaNova and to our Executive Leadership Team as our new CFO. Thad is equipped with a strong healthcare and medical device background, coupled with the financial acumen and acuity to enhance our strategic growth plans. I look forward to working together to drive performance, build our pipeline and expand our portfolio in a sustainable manner,” CEO Damien McDonald said in a press release.
Teleflex (NYSE:TFX) said this month it promoted its VP and corporate controller John Deren to VP and chief accounting officer.
Prior to his joining Teleflex, Deren acted as VP and global controller at materials manufacturer Trinseo S.A., held financial management positions with energy provider Excelon Corp and specialty chemical group Haas Company and worked as a senior manager at PricewaterhouseCoopers.
Novartis‘ (NYSE:NVS) eye care business Alcon has picked up Dr. Stephen Lane as its new chief medical officer, according to a Healio report.
Lane was a founding partner of Associated Eye Care, and a former president of the American Society of Cataract and Refractive Surgery, according to the report.
“His extensive experience in ophthalmic surgery, contact lens and intraocular lens development, clinical trial design and execution, and the regulatory environment complements Alcon’s medical device innovation and commercial execution strategy,” senior VP & global R&D head Franck Leveiller said, according to the Healio report.
Video eyewear and smart glass supplier Vuzix said this month it tapped Paul Boris as its COO.
Boris has served as a director at the company since June last year, Vuzix said. Prior to his time with Vuzix, Boris served as director of the National Association of Manufacturers, and has held positions with GE including advanced manufacturing strategy CIO.
As part of his move to COO, Boris will resign as director and not stand for re-election, according to an SEC filing from the company.
Cardiovascular Systems (NSDQ:CSII) said last week that its senior VP of manufacturing, operations & quality will step down from the company.
The company said it is in discussions with Koehn as to the final date of employment with the company, and that it would disclose terms of the separation agreement following the execution of such an agreement.
- Brainlab CFO Doyle to retire
- SightLife Surgical adds Haffey as chief commercial officer
- Fortimedix adds Castiglioni as US sales VP
- Nativis taps Murray as chief regulatory officer
- Stimwave appoints Tompkins as sales exec VP
The post LivaNova snags former J&J exec Huston as CFO | Personnel Moves, May 24, 2017 appeared first on MassDevice.
from MassDevice http://ift.tt/2qWOpXu
Cap comentari:
Publica un comentari a l'entrada